STERIS plc (STE) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Medical Devices industry.
Over the past 4 years, STERIS plc has achieved a revenue compound annual growth rate (CAGR) of 46.6%, while earnings have grown at 49.4% CAGR.
Historical revenue and profitability trends for STERIS plc
The chart above illustrates STERIS plc's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of STERIS plc's business.
How efficiently STERIS plc converts revenue into profit
Profit margins reveal how much of each dollar of revenue STERIS plc retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project STERIS plc to continue growing earnings in the coming year. The consensus analyst rating is 3.8 based on 10 analysts.
Based on our comprehensive analysis, STERIS plc (STE) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of STERIS plc's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how STERIS plc stacks up against similar companies
Explore growth analysis for top stocks
Related: STE Valuation, STE Dividend, STE Financial Health
Compare: STE vs AAPL, STE vs MSFT, STE vs GOOGL